Ascertained COVID (n = 9) | Non COVID (n = 287) | p value | |
---|---|---|---|
General (n = 296) | |||
Age years-old, mean (SD) | 46.22 (9.55) | 53.15 (17.78) | 0.25 |
Range | 35–65 | 3–86 | |
Gender (female), n (%) | 3 (33.3) | 154 | 0.31 |
Clinical, HHT-related (n = 296)a | |||
Epistaxis, n (%) | 9/9 (100) | 274/287 (95.5) | 1 |
PAVMs, n (%) | 2/9 (22.2) | 98/270 (36.3) | 0.5 |
BAVMs, n (%) | 0 | 27/226 (11.9) | 0.4 |
HAVMs, n (%) | 2/9 (22.2) | 102/266 (38.3) | 1 |
GI bleeding, n (%) | 1/9 (11.1) | 51/287 (17.8) | 1 |
Mutated gene (n = 296) | |||
Identified Mutation, n (%) | 9 (100) | 227 (79.1) | 0.13 |
ENG | 3 (33.3) | 83 (29) | |
ALK1/ACVRL1 | 6 (66.7) | 143 (49.8) | |
SMAD4 | 0 | 1 (0.3) | |
Mutation unidentified/Ongoing analysis, n (%) | 0 | 60 (20.9) |